<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC4046633/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046633/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Inflammatory bowel diseases"><meta name="citation_title" content="Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients"><meta name="citation_authors" content="Adam Weizman, Brian Huang, Dror Berel, Stephan R. Targan, Marla Dubinsky, Phillip Fleshner, Andrew Ippoliti, Manreet Kaur, Deepa Panikkath, Steve Brant, Ioannis Oikonomou, Rick Duerr, John Rioux, Mark Silverberg, Jerome I Rotter, Eric Vasiliauskas, Talin Haritunians, David Shih, Dalin Li, Gil Y. Melmed, Dermot P.B. McGovern"><meta name="citation_date" content="March 2014"><meta name="citation_issue" content="3"><meta name="citation_volume" content="20"><meta name="citation_firstpage" content="525"><meta name="citation_doi" content="10.1097/01.MIB.0000442011.60285.68"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4046633/?report=abstract"><meta name="citation_pmid" content="24487271"><meta name="DC.Title" content="Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Adam Weizman"><meta name="DC.Contributor" content="Brian Huang"><meta name="DC.Contributor" content="Dror Berel"><meta name="DC.Contributor" content="Stephan R. Targan"><meta name="DC.Contributor" content="Marla Dubinsky"><meta name="DC.Contributor" content="Phillip Fleshner"><meta name="DC.Contributor" content="Andrew Ippoliti"><meta name="DC.Contributor" content="Manreet Kaur"><meta name="DC.Contributor" content="Deepa Panikkath"><meta name="DC.Contributor" content="Steve Brant"><meta name="DC.Contributor" content="Ioannis Oikonomou"><meta name="DC.Contributor" content="Rick Duerr"><meta name="DC.Contributor" content="John Rioux"><meta name="DC.Contributor" content="Mark Silverberg"><meta name="DC.Contributor" content="Jerome I Rotter"><meta name="DC.Contributor" content="Eric Vasiliauskas"><meta name="DC.Contributor" content="Talin Haritunians"><meta name="DC.Contributor" content="David Shih"><meta name="DC.Contributor" content="Dalin Li"><meta name="DC.Contributor" content="Gil Y. Melmed"><meta name="DC.Contributor" content="Dermot P.B. McGovern"><meta name="DC.Date" content="2014 Mar"><meta name="DC.Identifier" content="10.1097/01.MIB.0000442011.60285.68"><meta name="DC.Language" content="en"><meta property="og:title" content="Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients"><meta property="og:type" content="article"><meta property="og:description" content="Pyoderma gangrenosum (PG) and erythema nodosum (EN) are the most common cutaneous manifestations of inflammatory bowel disease (IBD) but little is known regarding their etiopathogenesis.We performed a case control study comparing characteristics between ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046633/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC4046633/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC4046633/pdf/nihms554731.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8B32B3DD56A37100000000031501DA.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4046633%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed">PubMed</option><option value="protein" class="last">Protein</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC4046633</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Inflamm Bowel Dis</a></span>. Author manuscript; available in PMC 2015 Mar 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=24487271" target="pmc_ext" ref="reftype=publisher&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Inflamm Bowel Dis. 2014 Mar; 20(3): 525–533. </span></a></div> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1097%2F01.MIB.0000442011.60285.68" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1097/01.MIB.0000442011.60285.68</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4046633</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS554731</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/24487271">24487271</a></div></div></div></div><h1 class="content-title">Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Weizman%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122014575760" co-class="co-affbox">Adam Weizman</a>, MD,<sup>*,</sup><sup>1</sup> <a href="/pubmed/?term=Huang%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122014573488" co-class="co-affbox">Brian Huang</a>, MD,<sup>*,</sup><sup>1</sup> <a href="/pubmed/?term=Berel%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122013010880" co-class="co-affbox">Dror Berel</a>, PhD,<sup>1</sup> <a href="/pubmed/?term=Targan%20SR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122011364688" co-class="co-affbox">Stephan R. Targan</a>, MD,<sup>1</sup> <a href="/pubmed/?term=Dubinsky%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122011362448" co-class="co-affbox">Marla Dubinsky</a>, MD,<sup>2</sup> <a href="/pubmed/?term=Fleshner%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122011005584" co-class="co-affbox">Phillip Fleshner</a>, MD,<sup>1</sup> <a href="/pubmed/?term=Ippoliti%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122011003344" co-class="co-affbox">Andrew Ippoliti</a>, MD,<sup>1</sup> <a href="/pubmed/?term=Kaur%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122011122368" co-class="co-affbox">Manreet Kaur</a>, MD,<sup>1</sup> <a href="/pubmed/?term=Panikkath%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122007103840" co-class="co-affbox">Deepa Panikkath</a>, MD,<sup>1</sup> <a href="/pubmed/?term=Brant%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122007101600" co-class="co-affbox">Steve Brant</a>, MD,<sup>3</sup> <a href="/pubmed/?term=Oikonomou%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122008663984" co-class="co-affbox">Ioannis Oikonomou</a>, MD,<sup>4</sup> <a href="/pubmed/?term=Duerr%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122008661744" co-class="co-affbox">Rick Duerr</a>, MD,<sup>5</sup> <a href="/pubmed/?term=Rioux%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122008050720" co-class="co-affbox">John Rioux</a>, PhD,<sup>6</sup> <a href="/pubmed/?term=Silverberg%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122016068640" co-class="co-affbox">Mark Silverberg</a>, MD, PhD,<sup>7</sup> <a href="/pubmed/?term=Rotter%20JI%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122016066400" co-class="co-affbox">Jerome I Rotter</a>, MD,<sup>8</sup> <a href="/pubmed/?term=Vasiliauskas%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122012875152" co-class="co-affbox">Eric Vasiliauskas</a>, MD,<sup>1</sup> <a href="/pubmed/?term=Haritunians%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122012872912" co-class="co-affbox">Talin Haritunians</a>, PhD,<sup>9</sup> <a href="/pubmed/?term=Shih%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122015520544" co-class="co-affbox">David Shih</a>, MD, PhD,<sup>1</sup> <a href="/pubmed/?term=Li%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122013029008" co-class="co-affbox">Dalin Li</a>, PhD,<sup>9</sup> <a href="/pubmed/?term=Melmed%20GY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122013026768" co-class="co-affbox">Gil Y. Melmed</a>, MD, MPH,<sup>1</sup> and  <a href="/pubmed/?term=McGovern%20DP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271" class="affpopup" co-rid="_co_idm140122010048752" co-class="co-affbox">Dermot P.B. McGovern</a>, MD, PhD<sup>1,</sup><sup>9</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140122014575760"><h3 class="no_margin">Adam Weizman</h3><p><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Weizman%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Adam Weizman</a></div></div><div id="_co_idm140122014573488"><h3 class="no_margin">Brian Huang</h3><p><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Huang%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Brian Huang</a></div></div><div id="_co_idm140122013010880"><h3 class="no_margin">Dror Berel</h3><p><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Berel%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Dror Berel</a></div></div><div id="_co_idm140122011364688"><h3 class="no_margin">Stephan R. Targan</h3><p><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Targan%20SR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Stephan R. Targan</a></div></div><div id="_co_idm140122011362448"><h3 class="no_margin">Marla Dubinsky</h3><p><sup>2</sup>Departments of Pediatrics, Pediatric Inflammatory Bowel Disease Center, Cedars Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Dubinsky%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Marla Dubinsky</a></div></div><div id="_co_idm140122011005584"><h3 class="no_margin">Phillip Fleshner</h3><p><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Fleshner%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Phillip Fleshner</a></div></div><div id="_co_idm140122011003344"><h3 class="no_margin">Andrew Ippoliti</h3><p><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Ippoliti%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Andrew Ippoliti</a></div></div><div id="_co_idm140122011122368"><h3 class="no_margin">Manreet Kaur</h3><p><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Kaur%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Manreet Kaur</a></div></div><div id="_co_idm140122007103840"><h3 class="no_margin">Deepa Panikkath</h3><p><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Panikkath%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Deepa Panikkath</a></div></div><div id="_co_idm140122007101600"><h3 class="no_margin">Steve Brant</h3><p><sup>3</sup>Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, School of Medicine, and Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA</p><div>Find articles by <a href="/pubmed/?term=Brant%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Steve Brant</a></div></div><div id="_co_idm140122008663984"><h3 class="no_margin">Ioannis Oikonomou</h3><p><sup>4</sup>Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA</p><div>Find articles by <a href="/pubmed/?term=Oikonomou%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Ioannis Oikonomou</a></div></div><div id="_co_idm140122008661744"><h3 class="no_margin">Rick Duerr</h3><p><sup>5</sup>Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA</p><div>Find articles by <a href="/pubmed/?term=Duerr%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Rick Duerr</a></div></div><div id="_co_idm140122008050720"><h3 class="no_margin">John Rioux</h3><p><sup>6</sup>Universite de Montreal and the Montreal Heart Institute, Research Center, Montreal, Quebec, Canada</p><div>Find articles by <a href="/pubmed/?term=Rioux%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">John Rioux</a></div></div><div id="_co_idm140122016068640"><h3 class="no_margin">Mark Silverberg</h3><p><sup>7</sup>Mount Sinai Inflammatory Bowel Disease Center, University of Toronto, Toronto, Ontario, Canada</p><div>Find articles by <a href="/pubmed/?term=Silverberg%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Mark Silverberg</a></div></div><div id="_co_idm140122016066400"><h3 class="no_margin">Jerome I Rotter</h3><p><sup>8</sup>Institute for Translational Genomics and Population Sciences, Los Angeles BioMedical Research Institute and Department of Pediatrics, Harbor-UCLA Medical Center, Torrance, California, USA</p><div>Find articles by <a href="/pubmed/?term=Rotter%20JI%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Jerome I Rotter</a></div></div><div id="_co_idm140122012875152"><h3 class="no_margin">Eric Vasiliauskas</h3><p><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Vasiliauskas%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Eric Vasiliauskas</a></div></div><div id="_co_idm140122012872912"><h3 class="no_margin">Talin Haritunians</h3><p><sup>9</sup>Medical Genetics Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Haritunians%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Talin Haritunians</a></div></div><div id="_co_idm140122015520544"><h3 class="no_margin">David Shih</h3><p><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Shih%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">David Shih</a></div></div><div id="_co_idm140122013029008"><h3 class="no_margin">Dalin Li</h3><p><sup>9</sup>Medical Genetics Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Li%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Dalin Li</a></div></div><div id="_co_idm140122013026768"><h3 class="no_margin">Gil Y. Melmed</h3><p><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=Melmed%20GY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Gil Y. Melmed</a></div></div><div id="_co_idm140122010048752"><h3 class="no_margin">Dermot P.B. McGovern</h3><p><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><p><sup>9</sup>Medical Genetics Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</p><div>Find articles by <a href="/pubmed/?term=McGovern%20DP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24487271">Dermot P.B. McGovern</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140122009304784_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140122009304784_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140122009304784_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>Departments of Pediatrics, Pediatric Inflammatory Bowel Disease Center, Cedars Sinai Medical Center, Los Angeles, California, USA</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, School of Medicine, and Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA</div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA</div><div class="fm-affl" id="A6" lang="en"><sup>6</sup>Universite de Montreal and the Montreal Heart Institute, Research Center, Montreal, Quebec, Canada</div><div class="fm-affl" id="A7" lang="en"><sup>7</sup>Mount Sinai Inflammatory Bowel Disease Center, University of Toronto, Toronto, Ontario, Canada</div><div class="fm-affl" id="A8" lang="en"><sup>8</sup>Institute for Translational Genomics and Population Sciences, Los Angeles BioMedical Research Institute and Department of Pediatrics, Harbor-UCLA Medical Center, Torrance, California, USA</div><div class="fm-affl" id="A9" lang="en"><sup>9</sup>Medical Genetics Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA</div><div id="FN1">Correspondence: Dr. Dermot McGovern, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, 8797 Beverly Blvd – suite 300, Los Angeles, CA 90048, USA. <a href="mailto:dev@null" data-email="gro.shsc@nrevogcm.tomreD" class="oemail">gro.shsc@nrevogcm.tomreD</a></div><div id="FN2"><sup>*</sup>These authors contributed equally to this study</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140122009304784_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=24487271" target="pmc_ext" ref="reftype=publisher&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Inflamm Bowel Dis</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC4046633/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="3" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>1.</strong></div><div><a href="/pmc/articles/PMC4046633/bin/NIHMS554731-supplement-1.pdf" data-ga-action="click_feat_suppl">NIHMS554731-supplement-1.pdf</a><span style="color:gray"> (309K)</span></div><div class="small guid">GUID:&nbsp;4F82E1FC-B826-4D81-9754-B9EF940285E3</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>2.</strong></div><div><a href="/pmc/articles/PMC4046633/bin/NIHMS554731-supplement-2.pdf" data-ga-action="click_feat_suppl">NIHMS554731-supplement-2.pdf</a><span style="color:gray"> (511K)</span></div><div class="small guid">GUID:&nbsp;B29F393A-CDE1-41DB-81DC-62A9083FE50B</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>3.</strong></div><div><a href="/pmc/articles/PMC4046633/bin/NIHMS554731-supplement-3.pdf" data-ga-action="click_feat_suppl">NIHMS554731-supplement-3.pdf</a><span style="color:gray"> (310K)</span></div><div class="small guid">GUID:&nbsp;09D56959-865E-48EF-9393-20C2798BBA0B</div></div></dd></dl></div><div id="idm140122008025328" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140122008025328title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Objective</h3><p id="P1" class="p p-first-last">Pyoderma gangrenosum (PG) and erythema nodosum (EN) are the most common cutaneous manifestations of inflammatory bowel disease (IBD) but little is known regarding their etiopathogenesis.</p></div><div id="S2" class="sec"><h3 id="S2title">Design</h3><p id="P2" class="p p-first-last">We performed a case control study comparing characteristics between IBD patients with a documented episode of PG (PG+) and/or EN (EN+) with those without PG (PG-) and EN (EN-). Data on clinical features were obtained by chart review. IBD related serology was determined using ELISA and genome-wide data generated using Illumina technology. Standard statistical tests for association were used.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P3" class="p p-first-last">We identified a total 92 cases of PG and 103 cases of EN with genetic and clinical characteristics, of which 64 PG and 55 EN were available for serological analyses. Fewer male subjects were identified in the PG(+) (OR 0.6, p=0.009) and EN(+) groups (OR 0.31, p=0&lt;0.0001). Colonic disease, previous IBD related surgery, and non-cutaneous extra-intestinal manifestations were more common among both PG(+) and EN(+) patients compared to controls. PG(+) was associated with ANCA seropositivity (p=0.03) and higher ANCA level (p=0.02) in CD. Genetic associations with PG included known IBD loci (<em>IL8RA</em> (p=0.00003), and <em>PRDM1</em> (0.03)) as well as with <em>USP15</em> (4.8×10<sup>−6</sup>) and <em>TIMP3</em> (5.6 ×10<sup>−7</sup>). Genetic associations with EN included known IBD susceptibility genes (<em>PTGER4</em> (p=8.8×10<sup>−4</sup>), <em>ITGAL</em> (0.03)) as well as <em>SOCS5</em> (9.64×10<sup>−6</sup>), <em>CD207</em> 3.14×10<sup>−6</sup>), <em>ITGB3</em> (7.56×10<sup>−6</sup>) and r<em>s6828740</em> (4q26)(p &lt;5.0 × 10<sup>−8</sup>). Multivariable models using clinical, serologic, and genetic parameters predicted PG (AUC 0.8) and EN (AUC 0.97).</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Conclusion</h3><p id="P4" class="p p-first-last">Cutaneous manifestations in IBD are associated with distinctive genetic characteristics as well as with the similar clinical characteristics including the development of other extra-intestinal manifestations suggesting shared and distinct etiologies.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Crohn's disease, extra-intestinal manifestations, inflammatory bowel disease, pyoderma gangrenosum, erythema nodosum, ulcerative colitis, genetics, serology</span></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">Introduction</h2><p id="P5" class="p p-first">In addition to gastrointestinal tract pathology, the inflammatory bowel diseases are associated with extra-intestinal manifestations (EIMs). including cutaneous EIMs such as pyoderma gangrenosum (PG) and erythema nodosum (EN). While troublesome in their own right, EIMs may ‘tag’ more homogenous sub-groups within IBD with unique pathogenic characteristics.</p><p id="P6">PG, observed in 0.5-5% of IBD patients, is reportedly more commonly associated with colonic disease and is a significant source of morbidity requiring intensive, in-patient multi-disciplinary approaches to management [<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043401">2</a>, <a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043406">3</a>] [<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043443">4</a>-<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043429">7</a>]. PG is a neutrophilic dermatosis and usually begins as a papule or pustule at a site of trauma with a surrounding violacious, undermined border [<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043428">8</a>]. PG can significantly affect activities of daily living, quality of life and can be cosmetically disfiguring leading to permanent scarring, significant pain, bacterial super-infection, and may require skin grafting [<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043432">8</a>, <a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043431">9</a>]. Moreover, potent immunosuppression with therapeutic agents such as intravenous cyclosporine or infliximab may be needed [<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043411">10</a>, <a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043439">11</a>]. There is limited data on genetic associations with PG, although small studies have suggested association with <em>PSTPIP1, PTPN6</em>, and <em>TRAF3IP2</em> [<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043448">12</a>-<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043440">14</a>].</p><p id="P7">EN is the most common dermatologic manifestation in IBD and affects 3-15% of IBD patients [<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043410">15</a>-<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043408">17</a>]. Typically diagnosed clinically and rarely before the onset of IBD, lesions most commonly affect the anterior surface of the lower extremities in the form of tender, erythematous, and raised nodules with histology revealing a neutrophilic inflammatory infiltrate and panniculitis [<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043447">7</a>, <a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043414">18</a>-<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043415">20</a>] [<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043450">1</a>]. Previous studies have noted that EN is also associated with colonic disease [<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043427">16</a>] and with a more benign IBD natural history [<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043413">2</a>, <a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043405">16</a>]. Prior studies have suggested an association between the <em>HLA</em> and EN in IBD [<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043423">14</a>, <a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043397">23</a>].</p><p id="P8" class="p p-last">As researchers begin to understand the molecular characteristics of IBD, there is a need to better characterize sub-groups of these complex and heterogeneous conditions. An increased understanding of the etiology of both PG and EN in IBD may highlight potential novel therapeutic pathways for the sub-set of patients who are at risk for skin manifestations. The aim of this study was to better characterize IBD disease behavior, serologic profiles, and genetic associations among patients with PG or EN.</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">Methods</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Subjects</h3><p id="P9" class="p p-first">We reviewed two large IBD databases for cases of PG and EN. The Cedars-Sinai Medical Center IBD Research Repository contains clinical (demographics, disease phenotype, disease history, EIMs, treatment records), serologic, and genetic data on over 5000 consented IBD patients followed at our center. From this database, we identified all subjects with genome wide association (GWA) genotyping for inclusion in this study [<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043425">24</a>, <a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043416">25</a>]. Those subjects with at least one documented episode of PG [PG(+)] or EN [EN(+)] were identified and underwent a detailed confirmatory medical record review. Subjects without a history of PG [PG(−)]or EN [EN(−)] formed the control group. An episode of PG was confirmed on record review based on either dermatology consultant impression or typical features, as defined elsewhere as having three or more of the following: (i) leg or peristomal location (ii) pathergy (iii) initial pustular lesion (iv) purulent discharge (v) violacious or undermined borders (vi) crater like holes/cribiform scarring [<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043449">26</a>]. Histology was reviewed, when available, to exclude alternative diagnoses. An episode of EN was confirmed via chart review by dermatology consultation or typical features including erythematous, non-ulcerative, raised, tender bruise-like lesions usually on the legs.</p><p id="P10" class="p p-last">We also included IBD cases with GWA data available from the National Institute for Diabetes and Digestive and Kidney Diseases IBD Genetics Consortium (NIDDK-IBDGC) (Cedars-Sinai Medical Center, Johns Hopkins University, University of Montreal, University of Pittsburgh, University of Toronto, Yale University, and University of Chicago (Data Coordinating Center). The validity and reliability of the clinical features collected in this database has been previously documented [<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043435">28</a>]. The clinical and genetic data on IBD patients (care was taken to exclude any CSMC patients in the NIDDK cohort in order to avoid double ‘reporting’) were combined with the samples from the CSMC database (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figures 1a and 1b</a>). The serologic analysis was limited to the subjects identified in the CSMC IBD Research Repository. The CSMC IBD Research Repository contained 4137 IBD subjects with GWA data. Of these, 64 were PG(+), 55EN(+), and 4073 PG/EN(−). The NIDDK IBDGC database contained 1619 IBD subjects with GWA data (28 PG(+), 48(EN+), and 1591 PG/EN(−)). The genetic and clinical analyses were performed on the combined datasets. Therefore, this analysis consisted of 5756 subjects (92 PG(+), 103 EN(+), and 5664 PG/EN(−)). The serologic analysis was limited to the subjects in the CSMC IBD Research Repository (total 4137 subjects: 64 PG(+), 55 EN(+); and 4073 PG/EN(−)). A total of 14 patients with both EN and PG were identified and were included in both EN and PG analyses.</p></div><div id="S8" class="sec"><h3 id="S8title">Clinical and Serologic Phenotyping</h3><p id="P11" class="p p-first-last">Clinical data were collected at all contributing centers by chart review and included patient demographics (age, gender, ethnicity, race), family history, disease duration, disease phenotype (IBD subtype and disease location/behavior according to the Montreal Classification), surgical history, treatment record, smoking status, and presence or absence of other extra-intestinal manifestations [<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043420">29</a>]. IBD-associated serologies (anti-saccharomyces cerevisiae antibodies (ASCA IgG and IgA), perinuclear anti-nuclear cytoplasmic antibody (pANCA), anti-flagellin (anti-CBir1), anti-outer membrane porin C (anti-OmpC) and anti-Pseudomonas fluorescens-associated sequence I2 (anti-I2) were measured by ELISA, as previously described [<a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043396">30</a>]. Antibody levels were determined and results expressed as ELISA units (EU/mL) that are relative to CSMC laboratory (immunoglobulin [Ig] A-I2, IgA-OmpC) or a Prometheus Laboratory standard (SanDiego, CA; IgA and IgG ASCA) having been derived from a pool of patient sera with well-characterized disease found to have reactivity to these antigens. Quantitation of IgG anti-CBir1 reactivity was expressed in ELISA units derived based on a proportion of reactivity relative to a standardized positive control. Quantitative serologic results were converted to binary variables (i.e. positive or negative). Qualitative positivity to any antibody was defined as being greater than cut-off values 2 standard deviations above mean control titers for each assay. All assays were performed blind to any knowledge of patient clinical characteristics.</p></div><div id="S9" class="sec"><h3 id="S9title">Genotyping and genotype quality control</h3><p id="P12" class="p p-first-last">Genotyping was performed at Cedars Sinai Medical Center using Illumina Human610 platforms for CD and HumanCNV370 platforms for UC [<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043417">23</a>, <a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043436">24</a>]. The NIDDK IBDGC samples were genotyped using the HumanHap300 and HumanHap550 platforms as previously described [<a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_461805875">31</a>, <a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043412">32</a>]. In the genotyped datasets individual and genotype missingness, allele frequencies, and deviations from Hardy-Weinberg Equilibrium were calculated using the PLINK software package (<a href="http://pngu.mgh.harvard.edu/~purcell/plink" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://pngu.mgh.harvard.edu/∼purcell/plink</a>). Of the 5756 IBD cases, 21 failed quality control (QC) metrics, in which we required a genotyping call rate of &gt; 95%, inbreeding coefficient of &lt; 0.05, and lack of cryptic relatedness which was defined as unexpected relatedness not reflected by known family structure and can sometimes be caused by sample contamination. Analysis of population substructure with Eigenstrat identified 134 subjects that were outside of the main Caucasian cluster on principle components analysis and those subjects were subsequently removed. SNPs with a call rate of &lt; 0.95, with minor allele frequency (MAF) of &lt; 0.01, and that strongly deviated from Hardy-Weinberg equilibrium (P &lt; 1 × 10<sup>−7</sup>) were removed. After the cleaning of the genotype datasets, for comparison purpose, we imputed SNPs separately for each genotyping platform using IMPUTE2 (mathgen.stats.ox.ac.uk/impute/impute_v2.html) with the HapMap Phase 2 (<a href="http://www.hapmap.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.hapmap.org</a>, all population groups combined) serving as the reference. After the imputation, a further stringent cleaning procedure was applied thereby removing any imputed SNP with a certainty score below 0.8, quality score below 0.5 and MAF &lt; 0.01 in any of the cohorts, leaving 2,017,629 SNPs available for analysis.</p></div><div id="S10" class="sec"><h3 id="S10title">Statistical Analysis</h3><div id="S11" class="sec sec-first"><p></p><h4 id="S11title" class="inline">Univariate analysis </h4><p id="P13" class="p p-first-last">Univariate analyses were conducted to test for differences between PG(+) and PG(−) subjects and between EN(+) and EN(−) subjects. Fisher Exact Test was used to test for associations between PG/EN status and clinical characteristics. Serology was assessed both qualitatively (i.e. percent seropositive) and quantitatively (i.e. median antibody level) using the Fisher's Exact Test and the Wilcoxon Rank Sum Test, respectively. A p-value &lt;0.05 was considered statistically significant.</p></div><div id="S12" class="sec"><p></p><h4 id="S12title" class="inline">Genetic analysis </h4><p id="P14" class="p p-first-last">In the imputed datasets, the association between PG and EN status and each single SNP were evaluated using logistic regression with SNPTEST(<a href="http://mathgen.stats.ox.ac.uk/genetics_software/snptest/snptest.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://mathgen.stats.ox.ac.uk/genetics_software/snptest/snptest.html</a>) in the Cedars and NIDDK cohorts separately. Top 4 principle components calculated using Eigenstrat (<a href="http://genepath.med.harvard.edu/~reich/Software.htm" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://genepath.med.harvard.edu/∼reich/Software.htm</a>)were included in the analysis to control for potential confounding effects due to population structure. We then performed a meta-analysis combining the Cedars and NIDDK cohorts to obtain combined estimates using an inverse variance weighting of cohort-specific estimates. Genetic associations with PG and EN were assessed using both a genome wide approach using, given that the skin EIMs are rare conditions, a nominal level of significance of p&lt;5×10<sup>−5</sup>, and at 99 previously identified IBD susceptibility loci using a level of significance of p&lt;0.05 [<a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043430">33</a>, <a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043398">34</a>].</p></div><div id="S13" class="sec sec-last"><p></p><h4 id="S13title" class="inline">Multivariable analysis </h4><p id="P15" class="p p-first-last">Models to predict PG/EN development were created using step-wise multiple logistic regression, combining IBD clinical features, serology, significant IBD susceptibility SNP's, and top GWA hits. The models built for PG analysis included: (1) clinical features alone, (2) serology alone, (3) genetics alone, (4) clinical features + serology, and (5) clinical features + serology + genetic associations. The models build for EN analysis included (1) genetics alone, (2) clinical features alone, and (3) clinical + genetics. The area under the Receiver Operating Characteristic (ROC) curve (AUC [95% CI]) was used to measure the predictive performance of these models for PG and EN.</p></div></div><div id="S14" class="sec sec-last"><h3 id="S14title">Ethical Considerations</h3><p id="P16" class="p p-first-last">The Institutional Review Board at Cedars-Sinai Medical Center and the GRCs of the NIDDK IBDGC approved this study and enrolled subjects had provided written informed consent.</p></div></div><div id="S15" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S15title">Results</h2><div id="S16" class="sec sec-first"><h3 id="S16title">Clinical Associations</h3><div id="S17" class="sec sec-first"><p></p><h4 id="S17title" class="inline">Pyoderma Gangrenosum </h4><p id="P17" class="p p-first">Overall, 92 PG(+) cases were identified among 5756 subjects for the genetic and clinical analysis while the serologic analysis was limited to 64 PG(+) among 4137 samples (see Methods section above and <a href="#SD1" rid="SD1" class=" supplementary-material">supplementary figures 1a and 1b</a>).</p><p id="P18" class="p p-last"><a href="/pmc/articles/PMC4046633/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1a</span></a> shows the demographic and disease features stratified according to PG status. PG was more common in women and patients with PG were diagnosed with IBD at an older age. Among those with CD, fewer subjects had small bowel disease in the PG(+) group but perianal disease and colonic disease were more common compared to the PG(−) group. Eye EIMs (i.e. iritis, uveitis), IBD associated arthritis and ankylosing spondylitis were more prevalent among those with PG.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Clinical and Demographic Characteristics of PG Cohort</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140122012586240" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="middle" align="left">Clinical Feature</th><th rowspan="1" colspan="1" valign="middle" align="center">PG(+), n = 92 (%)</th><th rowspan="1" colspan="1" valign="middle" align="center">PG(−), n = 5664 (%)</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center">OR (95% CI)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">Male</td><td rowspan="1" colspan="1" valign="top" align="center">34 (37)</td><td rowspan="1" colspan="1" valign="top" align="center">2825 (51)</td><td rowspan="1" colspan="1" valign="top" align="center">0.009</td><td rowspan="1" colspan="1" valign="top" align="center">0.6 (0.4–0.9)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Crohn's disease</td><td rowspan="1" colspan="1" valign="top" align="center">57 (62)</td><td rowspan="1" colspan="1" valign="top" align="center">3580 (63)</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Ulcerative colitis/IBDU</td><td rowspan="1" colspan="1" valign="top" align="center">35 (38)</td><td rowspan="1" colspan="1" valign="top" align="center">1851 (37)</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Mean age of IBD onset (yr)</td><td rowspan="1" colspan="1" valign="top" align="center">28.5</td><td rowspan="1" colspan="1" valign="top" align="center">24.8</td><td rowspan="1" colspan="1" valign="top" align="center">0.026</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Active smoking</td><td rowspan="1" colspan="1" valign="top" align="center">30 (33)</td><td rowspan="1" colspan="1" valign="top" align="center">869 (26)</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Family history of IBD</td><td rowspan="1" colspan="1" valign="top" align="center">23 (27)</td><td rowspan="1" colspan="1" valign="top" align="center">439 (20)</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Small bowel involvement</td><td rowspan="1" colspan="1" valign="top" align="center">43 (77)</td><td rowspan="1" colspan="1" valign="top" align="center">1403 (88)</td><td rowspan="1" colspan="1" valign="top" align="center">0.021</td><td rowspan="1" colspan="1" valign="top" align="center">0.5 (0.2–0.9)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Perianal CD</td><td rowspan="1" colspan="1" valign="top" align="center">33 (54)</td><td rowspan="1" colspan="1" valign="top" align="center">470 (29)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">2.8 (1.6–4.7)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Colonic disease</td><td rowspan="1" colspan="1" valign="top" align="center">55 (89)</td><td rowspan="1" colspan="1" valign="top" align="center">1148 (71)</td><td rowspan="1" colspan="1" valign="top" align="center">0.001</td><td rowspan="1" colspan="1" valign="top" align="center">3.2 (1.5–7.1)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">CD disease behavior</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> B1</td><td rowspan="1" colspan="1" valign="top" align="center">19 (34)</td><td rowspan="1" colspan="1" valign="top" align="center">623 (39)</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> B2</td><td rowspan="1" colspan="1" valign="top" align="center">17 (30)</td><td rowspan="1" colspan="1" valign="top" align="center">659 (41)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> B3</td><td rowspan="1" colspan="1" valign="top" align="center">25 (45)</td><td rowspan="1" colspan="1" valign="top" align="center">514 (32)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Previous IBD-related surgery</td><td rowspan="1" colspan="1" valign="top" align="center">61 (66)</td><td rowspan="1" colspan="1" valign="top" align="center">1629 (48)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">2.2 (1.4–3.4)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">IBD-associated arthritis</td><td rowspan="1" colspan="1" valign="top" align="center">26 (28)</td><td rowspan="1" colspan="1" valign="top" align="center">248 (9)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">3.8 (2.4–6.1)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Ankylosing spondylitis</td><td rowspan="1" colspan="1" valign="top" align="center">4 (4)</td><td rowspan="1" colspan="1" valign="top" align="center">31 (1)</td><td rowspan="1" colspan="1" valign="top" align="center">0.029</td><td rowspan="1" colspan="1" valign="top" align="center">3.8 (1.3–11)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Ophthalmologic (iritis, uveitis)</td><td rowspan="1" colspan="1" valign="top" align="center">18 (20)</td><td rowspan="1" colspan="1" valign="top" align="center">93 (4)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">6.7 (3.8–11.5)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Primary sclerosing cholangitis</td><td rowspan="1" colspan="1" valign="top" align="center">2 (2)</td><td rowspan="1" colspan="1" valign="top" align="center">51 (2)</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr></tbody></table></div><div id="largeobj_idm140122012586240" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4046633/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><p id="__p6" class="p p-first-last">OR, odds ratio; IBDU, inflammatory bowel disease unclassified.</p></div></div></div></div><div id="S18" class="sec sec-last"><p></p><h4 id="S18title" class="inline">Erythema Nodosum </h4><p id="P19" class="p p-first">Overall, 103 EN(+) cases were identified among 5756 subjects for the genetic and clinical analysis while the serologic analysis was limited to 55 EN(+) among 4137 samples (see Methods section and <a href="#SD1" rid="SD1" class=" supplementary-material">supplementary figures 1a and 1b</a>).</p><p id="P20" class="p p-last">Demographic and clinical characteristics associated with EN are shown in <a href="/pmc/articles/PMC4046633/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>table 1b</span></a>. Similar to the findings seen in PG, EN co-occured with other EIMs and was more common in women and patients with colonic disease.</p></div></div><div id="S19" class="sec"><h3 id="S19title">Serologic Associations</h3><p id="P21" class="p p-first-last">CD patients with PG were more likely to be ASCA negative, CBir1 negative and ANCA positive as well as having lower median ASCA and higher median ANCA levels in keeping with colonic disease location (<a href="#SD1" rid="SD1" class=" supplementary-material">supplementary figure 2a and 2b</a>). No significant associations were seen between IBD-associated serologies and EN apart from a borderline association with median anti-CBir1 level (<a href="#SD1" rid="SD1" class=" supplementary-material">supplementary figures 2c and 2d</a>) in CD cases. No significant serological differences were seen in UC between the two groups (data not shown).</p></div><div id="S20" class="sec"><h3 id="S20title">Genetic Associations</h3><div id="S21" class="sec sec-first"><p></p><h4 id="S21title" class="inline">Pyoderma Gangrenosum </h4><p id="P22" class="p p-first-last">A number of known IBD susceptibility loci showed significant association with PG including the loci containing <em>IL8RA</em> (p=0.00003), <em>MUC17</em> (0.01), <em>MMP24</em> (0.01), <em>WNK2</em> (0.01), <em>DOCK9</em> (0.02), <em>PRDM1</em> (p=0.03) and <em>NDIFIP1</em> (0.04) (<a href="/pmc/articles/PMC4046633/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>table 3a</span></a>). While no genetic associations with PG reached a genome wide level of significance, several SNP's met the nominal level of significance of p&lt;5×10<sup>−5</sup> (<a href="/pmc/articles/PMC4046633/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>table 2a</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">supplementary figure 2a</a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Clinical and Demographic Characteristics of EN Cohort</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140122013648224" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="middle" align="left">Clinical Feature</th><th rowspan="1" colspan="1" valign="middle" align="center">EN(+), n = 103 (%)</th><th rowspan="1" colspan="1" valign="middle" align="center">EN(−), n = 5664 (%)</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center">OR (95% CI)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">Male</td><td rowspan="1" colspan="1" valign="top" align="center">25 (24)</td><td rowspan="1" colspan="1" valign="top" align="center">2823 (51)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">0.3 (0.2–0.5)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Crohn's disease</td><td rowspan="1" colspan="1" valign="top" align="center">69 (67)</td><td rowspan="1" colspan="1" valign="top" align="center">3578 (66)</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Ulcerative colitis/IBDU</td><td rowspan="1" colspan="1" valign="top" align="center">34 (33)</td><td rowspan="1" colspan="1" valign="top" align="center">1851 (34)</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Mean age of IBD onset (yr)</td><td rowspan="1" colspan="1" valign="top" align="center">23.5</td><td rowspan="1" colspan="1" valign="top" align="center">24.8</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Active smoking</td><td rowspan="1" colspan="1" valign="top" align="center">70 (69)</td><td rowspan="1" colspan="1" valign="top" align="center">868 (26)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">6.2 (4.0–9.5)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Family history of JBD</td><td rowspan="1" colspan="1" valign="top" align="center">31 (30)</td><td rowspan="1" colspan="1" valign="top" align="center">439 (20)</td><td rowspan="1" colspan="1" valign="top" align="center">0.012</td><td rowspan="1" colspan="1" valign="top" align="center">1,8 (1.2–2.7)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Small bowel involvement</td><td rowspan="1" colspan="1" valign="top" align="center">36 (49)</td><td rowspan="1" colspan="1" valign="top" align="center">1405 (87)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">0.1 (0.1–0.2)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Perianal CD</td><td rowspan="1" colspan="1" valign="top" align="center">26 (30)</td><td rowspan="1" colspan="1" valign="top" align="center">470 (29)</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">1.0 (0.6–1.6)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Colonic disease</td><td rowspan="1" colspan="1" valign="top" align="center">77 (88)</td><td rowspan="1" colspan="1" valign="top" align="center">1148 (71)</td><td rowspan="1" colspan="1" valign="top" align="center">0.001</td><td rowspan="1" colspan="1" valign="top" align="center">2.9 (1.5–5.5)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">CD disease behavior</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> B1</td><td rowspan="1" colspan="1" valign="top" align="center">35 (48)</td><td rowspan="1" colspan="1" valign="top" align="center">623 (39)</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> B2</td><td rowspan="1" colspan="1" valign="top" align="center">21 (30)</td><td rowspan="1" colspan="1" valign="top" align="center">659 (41)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> B3</td><td rowspan="1" colspan="1" valign="top" align="center">29 (41)</td><td rowspan="1" colspan="1" valign="top" align="center">514 (32)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Previous IBD-related surgery</td><td rowspan="1" colspan="1" valign="top" align="center">68 (66)</td><td rowspan="1" colspan="1" valign="top" align="center">1628 (48)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">2.1 (1.4–3.2)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">IBD-associated arthritis</td><td rowspan="1" colspan="1" valign="top" align="center">49 (48)</td><td rowspan="1" colspan="1" valign="top" align="center">248 (9)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">8.7 (5.8–13.1)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Ankylosing spondylitis</td><td rowspan="1" colspan="1" valign="top" align="center">2 (2)</td><td rowspan="1" colspan="1" valign="top" align="center">31 (1)</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">3.8 (1.3–11)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Ophthalmologic (iritis, uveitis)</td><td rowspan="1" colspan="1" valign="top" align="center">26 (25)</td><td rowspan="1" colspan="1" valign="top" align="center">93 (4)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">9.2 (5.6–15)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Primary sclerosing cholangitis</td><td rowspan="1" colspan="1" valign="top" align="center">2 (2)</td><td rowspan="1" colspan="1" valign="top" align="center">34 (3)</td><td rowspan="1" colspan="1" valign="top" align="center">NS</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr></tbody></table></div><div id="largeobj_idm140122013648224" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4046633/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN2"><p id="__p7" class="p p-first-last">OR, odds ratio; TBDU, inflammatory bowel disease unclassified.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Genetic Associations with PG Assessed at Known IBD Susceptibility Loci</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140122010556208" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="middle" align="left">SNP</th><th rowspan="1" colspan="1" valign="middle" align="center">“Risk” Allele</th><th rowspan="1" colspan="1" valign="middle" align="center">Chromosome</th><th rowspan="1" colspan="1" valign="middle" align="left"><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center">OR (95% CI)</th><th rowspan="1" colspan="1" valign="middle" align="center">Gene</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">rs2382817</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">2q35</td><td rowspan="1" colspan="1" valign="top" align="left">0.00003</td><td rowspan="1" colspan="1" valign="top" align="center">0.4 (0.3–0.6)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>IL8RA, TMBIM1, TNS1, GPBAR1, ILSRB</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs1734907</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">7q22</td><td rowspan="1" colspan="1" valign="top" align="left">0.01</td><td rowspan="1" colspan="1" valign="top" align="center">1.8 (1.2–2.7)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>MUC17, AP1S1, SERPINE1, VGF, ARS2</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs6088765</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">20q11</td><td rowspan="1" colspan="1" valign="top" align="left">0.01</td><td rowspan="1" colspan="1" valign="top" align="center">1.6 (1.1–2.3)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>MMP24, PROCR, EIF6, EDEM2</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs4743820</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">9q22</td><td rowspan="1" colspan="1" valign="top" align="left">0.01</td><td rowspan="1" colspan="1" valign="top" align="center">0.6 (0.4–0.9)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>WNK2, NINJ1, ZNF484, FGD3, SUSD3</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs95S7195</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">13q32</td><td rowspan="1" colspan="1" valign="top" align="left">0.02</td><td rowspan="1" colspan="1" valign="top" align="center">0.6 (0.3–0.9)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>DOCK9, GPRI8, UBAC2, EBI2, TM9SF2</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs6568421</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">6q21</td><td rowspan="1" colspan="1" valign="top" align="left">0.03</td><td rowspan="1" colspan="1" valign="top" align="center">1.5 (1.1–2.2)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>PRDM1</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs11230563</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">11q12</td><td rowspan="1" colspan="1" valign="top" align="left">0.03</td><td rowspan="1" colspan="1" valign="top" align="center">1.5 (1.0–2.1)</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs6863411</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">5q31</td><td rowspan="1" colspan="1" valign="top" align="left">0.04</td><td rowspan="1" colspan="1" valign="top" align="center">0.7 (0.5–0.9)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>SPRY4, PCDHI2, GNPDA1, NDFIP1</em></td></tr></tbody></table></div><div id="largeobj_idm140122010556208" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4046633/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN3"><p id="__p8" class="p p-first-last">OR, odds ratio.</p></div></div></div></div><div id="S22" class="sec sec-last"><p></p><h4 id="S22title" class="inline">Erythema Nodosum </h4><p id="P23" class="p p-first-last">A number of known IBD susceptibility loci showed significant association with EN including <em>PTGER4</em> (p=8.7 × 10<sup>−4</sup>), <em>ITGAL</em> (0.03), and <em>IKZF1</em> (0.03) (<a href="/pmc/articles/PMC4046633/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>table 3b</span></a>). There were several SNP's that met the nominal level of genome-wide significance of p&lt;5×10<sup>−5</sup> (<a href="/pmc/articles/PMC4046633/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>table 2b</span></a>, <a href="#SD1" rid="SD1" class=" supplementary-material">supplementary figure 2b</a>). A SNP on chromosome 4q26 reached genome wide level (p = 4.94×10<sup>−8</sup>).</p></div></div><div id="S23" class="sec sec-last"><h3 id="S23title">Multivariable Logistic Regression Analysis</h3><div id="S24" class="sec sec-first"><p></p><h4 id="S24title" class="inline">Pyoderma Gangrenosum </h4><p id="P24" class="p p-first-last">Multiple logistic multiple regression was performed to create predictive models for PG development (<a href="/pmc/articles/PMC4046633/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>figure 1a</span></a>). Model 1 examined the importance of genetic associations in predicting PG. The SNP's rs2382817 (<em>IL8RA</em>) and rs130555 (<em>TIMP3)</em> remained significant in the model, with an AUC of 0.73 [95% CI 0.7-0.76]. Model II examined clinical features in predicting PG and a history of perianal disease and eye manifestations remained significant. Model III examined the significance of serology on PG, and p-ANCA status remained significant in this model while Model IV involved the combination of clinical features and serology. Finally, Model V examined the combination of clinical, serologic, and genetic data for predicting PG, and performed the best with an AUC of 0.80 [0.73-0.87].</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC4046633/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140122012976304" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms554731f1.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms554731f1.jpg" src="/pmc/articles/PMC4046633/bin/nihms554731f1.jpg"></div></a><div id="largeobj_idm140122012976304" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC4046633/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a target="object" href="/pmc/articles/PMC4046633/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC4046633/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p5">A, Multivariable model for predicting PG development. B, Multivariable model for predicting EN development.</p></div></div></div></div><div id="S25" class="sec sec-last"><p></p><h4 id="S25title" class="inline">Erythema Nodosum </h4><p id="P25" class="p p-first-last">Similar models were created for EN (<a href="/pmc/articles/PMC4046633/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>figure 1b</span></a>). Model 1 examined the predictive value of genetic associations in EN (AUC, 0.76 [95% CI 0.71-0.80]) and it appeared that using genetics alone was modestly predictive of EN development. Model II employed clinical features including gender, small bowel involvement, IBD related arthritis, and eye involvement with significantly greater success in predicting EN (AUC, 0.95 [95% CI 0.94-0.97]). Model III, a combination of clinical and genetic parameters, showed only a modest improvement than model II (AUC 0.97).</p></div></div></div><div id="S26" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S26title">Discussion</h2><p id="P26" class="p p-first">Extra-intestinal manifestations (EIMs) can often be more debilitating and difficult to treat than the underlying IBD and the ability to predict the development of these lesions could have implications on management. For example, patients at high-risk of PG may be educated regarding the importance of early detection and reporting of skin lesions. An increased understanding of the pathogenesis of EIMs may define sub-sets of disease and potentially identify novel therapeutic targets. The current study is among the first and largest in the IBD literature to characterize genetic, clinical and serologic associations of both PG and EN.</p><p id="P27">In keeping with previous findings, skin EIMs occur more commonly in women[<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043442">23</a>,<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043422">24</a>]. We observed that patients with PG were diagnosed with IBD at an older age and developed PG much later into IBD disease course, with a mean onset of 15 years after IBD diagnosis (data not shown), which is longer than the 2-7 years previously reported in the literature [<a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043424">36</a>, <a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043441">37</a>]. Earlier studies have suggested that PG was more common in UC, however more recent studies have shown stronger associations with CD [<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043434">6</a>, <a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043426">36</a>, <a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043407">38</a>]. In a population-based study, Bernstein et al. showed a prevalence of PG of 1.3% among CD patients compared to 0.8% among those with UC [<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043438">6</a>]. However, we found no difference in PG episodes among IBD disease type i.e. CD or UC in our cohort of patients largely collected from tertiary centers. While there are conflicting data, colonic disease has been more consistently demonstrated to be associated with EIM's [<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043444">17</a>, <a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043409">36</a>, <a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043452">39</a>] and our findings support this in both EN and PG. It has been proposed that the predominance of colonic disease in a subject with EIM's may be related to interactions between colonic disease and the microbiome with subsequent cross-reacting of skin, joint, eye, etc. antigens with gut antigens [<a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043437">40</a>]. A number of studies have demonstrated the co-occurrence of EIMs and this phenomenon is present in the cohorts from this study [<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043445">17</a>, <a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043433">39</a>]. In one study from Switzerland, patients with IBD-associated arthritis had an OR of 2.9 for subsequent PG development [<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043404">17</a>]. Moreover, certain EIM's tended to cluster, with EN and musculoskeletal manifestations commonly occurring together and PG occurring together with inflammatory eye manifestations. In this study, subjects with PG had a higher prevalence of iritis, uveitis, IBD associated arthritis, and ankylosing spondylitis (AS) and EN was associated with oral ulcers, IBD related arthritis, and ophthalmologic involvement providing additional evidence of common underlying pathophysiology to the IBD EIMs.</p><p id="P28">The genetic contributions to the EIMs remain unclear, however, we have identified several putative genetic associations (from the GWA approach) between IBD and PG including <em>GPBAR1</em> which encodes a G-protein involved in bile salt absorption, highly expressed in the ileum and colon, and interestingly, associated with PSC [<a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043402">44</a>, <a href="#R45" rid="R45" class=" bibr popnode">45</a>] providing additional evidence of shared etiology for the EIMs. PG was also associated with <em>TIMP3</em>, an important inhibitor of metalloproteinase involved in the degradation of the extracellular matrix [<a href="#R46" rid="R46" class=" bibr popnode">46</a>]. Given the large contribution of the extracellular matrix to skin morphology, this may be a particularly pertinent finding [<a href="#R47" rid="R47" class=" bibr popnode">47</a>]. We also identified associations between known IBD susceptibility genes and PG including <em>IL8RA</em>, a known mediator of neutrophil migration [<a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043421">33</a>, <a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043419">34</a>, <a href="#R48" rid="R48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043400">48</a>] which may be highly relevant given the role of neutrophils in PG pathogenesis. We identified several SNP's that met our nominal level of for genome wide significance (p&lt;5×10<sup>−5</sup>) and one SNP (<em>rs6828740)</em> reached the highly stringent level for genome wide level of significance (p&lt;5×10<sup>−8</sup>) for association with EN. This SNP, <em>rs6828740</em>, is located on chromosome 4q26 in a gene desert highly conserved across species that contains a binding site for <em>PRDM1</em>, a known IBD and autoimmune disease ‘gene’ also associated with PG development in this study (<a href="/pmc/articles/PMC4046633/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>table 1b</span></a>). Other putatively associated genes of interest include: <em>SOCS5</em> (2p21), a negative regulator of cytokine signaling [<a href="#R59" rid="R59" class=" bibr popnode">59</a>]; <em>CD207</em> (2p13), a non-classical antigen-processing pathway gene that facilitates uptake of antigens for presentation to T-cells [<a href="#R60" rid="R60" class=" bibr popnode">60</a>]; and <em>ITGB3</em> (17q21), an integrin involved with cell adhesion and cells-surface mediated signaling that is associated with asthma and diabetes susceptibility [<a href="#R61" rid="R61" class=" bibr popnode">61</a>]. Many of the genes that we have identified play a role in antigen presentation and cytokine signaling/production that contribute both, to the inflammation of the intestinal tract during IBD flares, as well as to the lympho-histiocytic infiltrate of the dermis and panniculitis seen with EN lesions [<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043399">1</a>].Our multivariable model for PG showed that the combination of clinical features, serology, and genetic associations performed better in predicting PG development than any variable alone. Our results add to the growing number of published examples of predictive multiplatform models. [<a href="#R49" rid="R49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_461805874">49</a>, <a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043446">50</a>].</p><p id="P29">We recognize that this study, despite being the largest of its type performed to date, has a number of limitations including the sample size. Furthermore, there is no definitive definition or definitive diagnostic test for PG or EN and all studies to date have been based on clinical impression from typical dermatologic features [<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_381043451">8</a>]. The diagnoses of PG and EN, in this study, were made by experienced IBD clinicians or dermatologists based at large tertiary referral IBD centers in North America. Reassuringly, our clinical associations with skin manifestations replicate results from other studies as well as identifying novel demographic, clinical, serological, and genetic associations. These findings should be replicated both independently and through combination with this existing cohort. The multivariable model represent an interesting and potentially powerful example of multiplatform predictive tools.</p><p id="P30" class="p p-last">In summary, we have better characterized the clinical, serologic, and genetic associations in IBD patients who develop PG or EN. While they are clearly distinct entities from one another, we demonstrate that there are shared associations suggesting common underlying mechanisms and pathways. These findings may also suggest potential novel therapeutic targets for managing these extra-intestinal manifestations including TIMP inhibitors and anti-cell adhesion strategies.</p></div><div id="unreferenced-ft" class="tsec sec headless whole_rhythm"><div class="unreferenced">​
                    <!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T4"><h3>Table 4</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Genetic Associations with PG Using a Genome-Wide Approach</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140122009762832" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="middle" align="left">SNP</th><th rowspan="1" colspan="1" valign="middle" align="center">“Risk” Allele</th><th rowspan="1" colspan="1" valign="middle" align="center">Chromosome</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center">OR (95% CI)</th><th rowspan="1" colspan="1" valign="middle" align="center">Genes</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">rs10184704</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">2q14</td><td rowspan="1" colspan="1" valign="top" align="center">6.3 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.3 (1.6–3.3)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>GYPC</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs13392177</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">2q35</td><td rowspan="1" colspan="1" valign="top" align="center">4.8 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.3 (1.6–3.4)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>APRC2/GPBAR1/HMG1L9</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs161857</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">5q23</td><td rowspan="1" colspan="1" valign="top" align="center">7.3 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.0 (1.9–4.9)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>TNFAIP8/HSD17B4/FABP5L6</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs11174436</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">12q14</td><td rowspan="1" colspan="1" valign="top" align="center">4.6 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.3 (1.6–3.4)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>FAM19A, USP15, MON2</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs12607055</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">18q12</td><td rowspan="1" colspan="1" valign="top" align="center">1.7 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.5 (2.1–5.9)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>RIT2/SYT4</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs17770334</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">18q21</td><td rowspan="1" colspan="1" valign="top" align="center">1.8 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.1 (1.9–4.8)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>SERP1NB3/4/5J7J11J13, BCL2, VPS4B, KDSR</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs130555</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">22q12</td><td rowspan="1" colspan="1" valign="top" align="center">5.6 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.5 (1.7–3.5)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>TIMP3</em></td></tr></tbody></table></div><div id="largeobj_idm140122009762832" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4046633/table/T4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN4"><p id="__p9" class="p p-first-last">OR, odds ratio.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T5"><h3>Table 5</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Genetic Associations with EN Assessed at Known IBD Susceptibility Loci</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140122011862208" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="middle" align="left">SNP</th><th rowspan="1" colspan="1" valign="middle" align="center">“Risk” Allele</th><th rowspan="1" colspan="1" valign="middle" align="center">Chromosome</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center">OR (95% CI)</th><th rowspan="1" colspan="1" valign="middle" align="center">Gene</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">rs11742570</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">5p13</td><td rowspan="1" colspan="1" valign="top" align="center">8.77 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.56 (0.4–0.8)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>PTGER4</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs11150589</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">16p11</td><td rowspan="1" colspan="1" valign="top" align="center">0.027</td><td rowspan="1" colspan="1" valign="top" align="center">1.41 (1.0–1.9)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>1TGAL</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs1456896</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">7p12</td><td rowspan="1" colspan="1" valign="top" align="center">0.03</td><td rowspan="1" colspan="1" valign="top" align="center">1.6 (1.1–2.3)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>IKZF1</em></td></tr></tbody></table></div><div id="largeobj_idm140122011862208" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4046633/table/T5/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN5"><p id="__p10" class="p p-first-last">OR, odds ratio.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T6"><h3>Table 6</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Genetic Associations with EN Using a Genome-Wide Approach</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140122085542336" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="middle" align="left">SNP</th><th rowspan="1" colspan="1" valign="middle" align="center">“Risk” Allele</th><th rowspan="1" colspan="1" valign="middle" align="center">Chromosome</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center">OR (95% CI)</th><th rowspan="1" colspan="1" valign="middle" align="center">Gene</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">rs7586612</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">2p21</td><td rowspan="1" colspan="1" valign="top" align="center">9.64 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.01 (1.5–2.7)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>SOCS5, MCFD2, TTC7A, CALM2</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs390966</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">2p13</td><td rowspan="1" colspan="1" valign="top" align="center">3.14 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.17 (1.6–3.0)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>CD207, NAGK, CLEC4F, MCEE</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs6828740</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">4q26</td><td rowspan="1" colspan="1" valign="top" align="center">4.94 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" valign="top" align="center">4.14 (2.5–6.9)</td><td rowspan="1" colspan="1" valign="top" align="center">—</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs9405444</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">6p25</td><td rowspan="1" colspan="1" valign="top" align="center">8.07 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.21 (1.6–3.1)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>FOXQ1</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs10138297</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">14q21</td><td rowspan="1" colspan="1" valign="top" align="center">7.29 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.63 (1.7–4.0)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>ARF6, METTL21D, SOS2</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs11079757</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">17</td><td rowspan="1" colspan="1" valign="top" align="center">7.6 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.2 (1.6–3.1)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>JTGB3, MYL4, CCD27</em></td></tr></tbody></table></div><div id="largeobj_idm140122085542336" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4046633/table/T6/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN6"><p id="__p11" class="p p-first-last">OR, odds ratio.</p></div></div></div></div></div><div id="S27" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S27title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>1</h4><div class="sup-box half_rhythm" id="d36e896"><a href="/pmc/articles/PMC4046633/bin/NIHMS554731-supplement-1.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(309K, pdf)</sup></div></div><div class="sec suppmat" id="SD2"><h4>2</h4><div class="sup-box half_rhythm" id="d36e900"><a href="/pmc/articles/PMC4046633/bin/NIHMS554731-supplement-2.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(511K, pdf)</sup></div></div><div class="sec suppmat" id="SD3"><h4>3</h4><div class="sup-box half_rhythm" id="d36e904"><a href="/pmc/articles/PMC4046633/bin/NIHMS554731-supplement-3.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(310K, pdf)</sup></div></div></div><div id="S28" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S28title">Acknowledgments</h2><div class="sec"><p id="__p2"><strong>Funding</strong>: This study was supported by The Helmsley Charitable Trust. IBD Research at Cedars-Sinai is supported by USPHS grant PO1DK046763 and the Cedars-Sinai F. Widjaja Foundation Inflammatory Bowel andImmunobiology Research Institute Research Funds. Genotyping at CSMC is supported in part by the National Center for Research Resources (NCRR) grant M01-RR00425, UCLA/Cedars-Sinai/Harbor/Drew Clinical and Translational Science Institute (CTSI) Grant (UL1 TR000124-01), the Southern California Diabetes and Endocrinology Research Grant (DERC) (DK063491). Project investigators are supported by The Helmsley Charitable Trust (D.P.B.M.), The European Union (D.P.B.M.), The Crohn's and Colitis Foundation of America (CCFA) (D.P.B.M.), The Feintech Family Chair in IBD (S.R.T.), The Joshua L. and Lisa Z. Greer Chair in IBD Genetics (D.P.B.M.), The Abe and Claire Levine Chair in Pediatric IBD (MD), and grants, DK062413, DK046763-19, AI067068, HS021747 (D.P.B.M.).</p></div></div><div id="idm140122005957648" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140122005957648title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN3"></p><p id="__p3" class="p p-first-last">AW and BH performed the chart review and wrote the first draft of the manuscript. DB performed the non-genetic and modeling associated statistical analyses. SRT recruited patients and obtained funding for the study. DPM, MD, PF, AI, MK, SB, IO, RD, JR, MS, and EV recruited and phenotyped subjects. DP phenotyped study subjects. JIR and TH performed and supervised genotyping and QCing of genotype data. DS, GYM, and DPM conceived and supervised the study.</p><p></p><p class="fn sec" id="FN4"></p><p id="__p4" class="p p-first-last"><strong><span class="underline">Disclosures:</span></strong> Marla Dubinsky and Mark Silverberg, consultant Prometheus Labs</p><p></p></div></div><div id="idm140122005954928" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140122005954928title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Huang BL, Chandra S, Shih DQ. Skin manifestations of inflammatory bowel disease. <span><span class="ref-journal">Front Physiol. </span>2012;<span class="ref-vol">3</span>:13.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3273725/">PMC free article</a>]</span> [<a href="/pubmed/22347192" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Physiol&amp;title=Skin+manifestations+of+inflammatory+bowel+disease&amp;author=BL+Huang&amp;author=S+Chandra&amp;author=DQ+Shih&amp;volume=3&amp;publication_year=2012&amp;pages=13&amp;pmid=22347192&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Tromm A, et al.  Cutaneous manifestations in inflammatory bowel disease. <span><span class="ref-journal">Z Gastroenterol. </span>2001;<span class="ref-vol">39</span>(2):137–44.</span> [<a href="/pubmed/11253504" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Z+Gastroenterol&amp;title=Cutaneous+manifestations+in+inflammatory+bowel+disease&amp;author=A+Tromm&amp;volume=39&amp;issue=2&amp;publication_year=2001&amp;pages=137-44&amp;pmid=11253504&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">McCallum DI, Kinmont PD. Dermatological manifestations of crohn's disease. <span><span class="ref-journal">Br J Dermatol. </span>1968;<span class="ref-vol">80</span>(1):1–8.</span> [<a href="/pubmed/5635591" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Dermatol&amp;title=Dermatological+manifestations+of+crohn's+disease&amp;author=DI+McCallum&amp;author=PD+Kinmont&amp;volume=80&amp;issue=1&amp;publication_year=1968&amp;pages=1-8&amp;pmid=5635591&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Lindgren A, Wallerstedt S, Olsson R. Prevalence of Crohn's disease and simultaneous occurrence of extraintestinal complications and cancer. An epidemiologic study in adults. <span><span class="ref-journal">Scand J Gastroenterol. </span>1996;<span class="ref-vol">31</span>(1):74–8.</span> [<a href="/pubmed/8927944" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scand+J+Gastroenterol&amp;title=Prevalence+of+Crohn's+disease+and+simultaneous+occurrence+of+extraintestinal+complications+and+cancer.+An+epidemiologic+study+in+adults&amp;author=A+Lindgren&amp;author=S+Wallerstedt&amp;author=R+Olsson&amp;volume=31&amp;issue=1&amp;publication_year=1996&amp;pages=74-8&amp;pmid=8927944&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. <span><span class="ref-journal">Medicine (Baltimore) </span>1976;<span class="ref-vol">55</span>(5):401–12.</span> [<a href="/pubmed/957999" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Medicine+(Baltimore)&amp;title=The+extra-intestinal+complications+of+Crohn's+disease+and+ulcerative+colitis:+a+study+of+700+patients&amp;author=AJ+Greenstein&amp;author=HD+Janowitz&amp;author=DB+Sachar&amp;volume=55&amp;issue=5&amp;publication_year=1976&amp;pages=401-12&amp;pmid=957999&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Bernstein CN, et al.  The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. <span><span class="ref-journal">Am J Gastroenterol. </span>2001;<span class="ref-vol">96</span>(4):1116–22.</span> [<a href="/pubmed/11316157" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Gastroenterol&amp;title=The+prevalence+of+extraintestinal+diseases+in+inflammatory+bowel+disease:+a+population-based+study&amp;author=CN+Bernstein&amp;volume=96&amp;issue=4&amp;publication_year=2001&amp;pages=1116-22&amp;pmid=11316157&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. <span><span class="ref-journal">Am J Gastroenterol. </span>1985;<span class="ref-vol">80</span>(8):615–20.</span> [<a href="/pubmed/4025277" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Gastroenterol&amp;title=Clinical+course+and+evolution+of+erythema+nodosum+and+pyoderma+gangrenosum+in+chronic+ulcerative+colitis:+a+study+of+42+patients&amp;author=SH+Mir-Madjlessi&amp;author=JS+Taylor&amp;author=RG+Farmer&amp;volume=80&amp;issue=8&amp;publication_year=1985&amp;pages=615-20&amp;pmid=4025277&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: classification and management. <span><span class="ref-journal">J Am Acad Dermatol. </span>1996;<span class="ref-vol">34</span>(3):395–409.</span> quiz 410-2. [<a href="/pubmed/8609250" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Pyoderma+gangrenosum:+classification+and+management&amp;author=FC+Powell&amp;author=WP+Su&amp;author=HO+Perry&amp;volume=34&amp;issue=3&amp;publication_year=1996&amp;pages=395-409&amp;pmid=8609250&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Thornton JR, et al.  Pyoderma gangrenosum and ulcerative colitis. <span><span class="ref-journal">Gut. </span>1980;<span class="ref-vol">21</span>(3):247–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1420361/">PMC free article</a>]</span> [<a href="/pubmed/7399325" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Pyoderma+gangrenosum+and+ulcerative+colitis&amp;author=JR+Thornton&amp;volume=21&amp;issue=3&amp;publication_year=1980&amp;pages=247-8&amp;pmid=7399325&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Friedman S, et al.  Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. <span><span class="ref-journal">Inflamm Bowel Dis. </span>2001;<span class="ref-vol">7</span>(1):1–7.</span> [<a href="/pubmed/11233655" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm+Bowel+Dis&amp;title=Intravenous+cyclosporine+in+refractory+pyoderma+gangrenosum+complicating+inflammatory+bowel+disease&amp;author=S+Friedman&amp;volume=7&amp;issue=1&amp;publication_year=2001&amp;pages=1-7&amp;pmid=11233655&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Regueiro M, et al.  Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. <span><span class="ref-journal">Am J Gastroenterol. </span>2003;<span class="ref-vol">98</span>(8):1821–6.</span> [<a href="/pubmed/12907338" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Gastroenterol&amp;title=Infliximab+for+treatment+of+pyoderma+gangrenosum+associated+with+inflammatory+bowel+disease&amp;author=M+Regueiro&amp;volume=98&amp;issue=8&amp;publication_year=2003&amp;pages=1821-6&amp;pmid=12907338&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Lin Z, et al.  Failure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to the PSTPIP1 gene. <span><span class="ref-journal">Inflamm Bowel Dis. </span>2011;<span class="ref-vol">17</span>(6):E41–2.</span> [<a href="/pubmed/21438098" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm+Bowel+Dis&amp;title=Failure+of+anakinra+treatment+of+pyoderma+gangrenosum+in+an+IBD+patient+and+relevance+to+the+PSTPIP1+gene&amp;author=Z+Lin&amp;volume=17&amp;issue=6&amp;publication_year=2011&amp;pages=E41-2&amp;pmid=21438098&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Nesterovitch AB, et al.  Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses. <span><span class="ref-journal">Am J Pathol. </span>2011;<span class="ref-vol">178</span>(4):1434–41.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3078441/">PMC free article</a>]</span> [<a href="/pubmed/21406173" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Pathol&amp;title=Alteration+in+the+gene+encoding+protein+tyrosine+phosphatase+nonreceptor+type+6+(PTPN6/SHP1)+may+contribute+to+neutrophilic+dermatoses&amp;author=AB+Nesterovitch&amp;volume=178&amp;issue=4&amp;publication_year=2011&amp;pages=1434-41&amp;pmid=21406173&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Ciccacci C, et al.  TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in Inflammatory Bowel Disease. <span><span class="ref-journal">J Crohns Colitis. </span>2012</span> [<a href="/pubmed/22445837" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Crohns+Colitis&amp;title=TRAF3IP2+gene+is+associated+with+cutaneous+extraintestinal+manifestations+in+Inflammatory+Bowel+Disease&amp;author=C+Ciccacci&amp;publication_year=2012&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Lebwohl M, Lebwohl O. Cutaneous manifestations of inflammatory bowel disease. <span><span class="ref-journal">Inflamm Bowel Dis. </span>1998;<span class="ref-vol">4</span>(2):142–8.</span> [<a href="/pubmed/9589299" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm+Bowel+Dis&amp;title=Cutaneous+manifestations+of+inflammatory+bowel+disease&amp;author=M+Lebwohl&amp;author=O+Lebwohl&amp;volume=4&amp;issue=2&amp;publication_year=1998&amp;pages=142-8&amp;pmid=9589299&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Timani S, Mutasim DF. Skin manifestations of inflammatory bowel disease. <span><span class="ref-journal">Clin Dermatol. </span>2008;<span class="ref-vol">26</span>(3):265–73.</span> [<a href="/pubmed/18640523" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Dermatol&amp;title=Skin+manifestations+of+inflammatory+bowel+disease&amp;author=S+Timani&amp;author=DF+Mutasim&amp;volume=26&amp;issue=3&amp;publication_year=2008&amp;pages=265-73&amp;pmid=18640523&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Vavricka SR, et al.  Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. <span><span class="ref-journal">Am J Gastroenterol. </span>2011;<span class="ref-vol">106</span>(1):110–9.</span> [<a href="/pubmed/20808297" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Gastroenterol&amp;title=Frequency+and+risk+factors+for+extraintestinal+manifestations+in+the+Swiss+inflammatory+bowel+disease+cohort&amp;author=SR+Vavricka&amp;volume=106&amp;issue=1&amp;publication_year=2011&amp;pages=110-9&amp;pmid=20808297&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Evans PE, Pardi DS. Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations. <span><span class="ref-journal">MedGenMed. </span>2007;<span class="ref-vol">9</span>(1):55.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1925026/">PMC free article</a>]</span> [<a href="/pubmed/17435655" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=MedGenMed&amp;title=Extraintestinal+manifestations+of+inflammatory+bowel+disease:+focus+on+the+musculoskeletal,+dermatologic,+and+ocular+manifestations&amp;author=PE+Evans&amp;author=DS+Pardi&amp;volume=9&amp;issue=1&amp;publication_year=2007&amp;pages=55&amp;pmid=17435655&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Trost LB, McDonnell JK. Important cutaneous manifestations of inflammatory bowel disease. <span><span class="ref-journal">Postgrad Med J. </span>2005;<span class="ref-vol">81</span>(959):580–5.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1743347/">PMC free article</a>]</span> [<a href="/pubmed/16143688" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Postgrad+Med+J&amp;title=Important+cutaneous+manifestations+of+inflammatory+bowel+disease&amp;author=LB+Trost&amp;author=JK+McDonnell&amp;volume=81&amp;issue=959&amp;publication_year=2005&amp;pages=580-5&amp;pmid=16143688&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Weinstein M, Turner D, Avitzur Y. Erythema nodosum as a presentation of inflammatory bowel disease. <span><span class="ref-journal">CMAJ. </span>2005;<span class="ref-vol">173</span>(2):145–6.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1174850/">PMC free article</a>]</span> [<a href="/pubmed/16027427" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=CMAJ&amp;title=Erythema+nodosum+as+a+presentation+of+inflammatory+bowel+disease&amp;author=M+Weinstein&amp;author=D+Turner&amp;author=Y+Avitzur&amp;volume=173&amp;issue=2&amp;publication_year=2005&amp;pages=145-6&amp;pmid=16027427&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Orchard T. Extraintestinal complications of inflammatory bowel disease. <span><span class="ref-journal">Curr Gastroenterol Rep. </span>2003;<span class="ref-vol">5</span>(6):512–7.</span> [<a href="/pubmed/14602062" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Gastroenterol+Rep&amp;title=Extraintestinal+complications+of+inflammatory+bowel+disease&amp;author=T+Orchard&amp;volume=5&amp;issue=6&amp;publication_year=2003&amp;pages=512-7&amp;pmid=14602062&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Kaufman I, et al.  The effect of infliximab on extraintestinal manifestations of Crohn's disease. <span><span class="ref-journal">Rheumatol Int. </span>2005;<span class="ref-vol">25</span>(6):406–10.</span> [<a href="/pubmed/15309501" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatol+Int&amp;title=The+effect+of+infliximab+on+extraintestinal+manifestations+of+Crohn's+disease&amp;author=I+Kaufman&amp;volume=25&amp;issue=6&amp;publication_year=2005&amp;pages=406-10&amp;pmid=15309501&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Orchard TR, et al.  Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. <span><span class="ref-journal">Gastroenterology. </span>2002;<span class="ref-vol">123</span>(3):714–8.</span> [<a href="/pubmed/12198697" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Uveitis+and+erythema+nodosum+in+inflammatory+bowel+disease:+clinical+features+and+the+role+of+HLA+genes&amp;author=TR+Orchard&amp;volume=123&amp;issue=3&amp;publication_year=2002&amp;pages=714-8&amp;pmid=12198697&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">McGovern DP, et al.  Genome-wide association identifies multiple ulcerative colitis susceptibility loci. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>(4):332–7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3087600/">PMC free article</a>]</span> [<a href="/pubmed/20228799" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+association+identifies+multiple+ulcerative+colitis+susceptibility+loci&amp;author=DP+McGovern&amp;volume=42&amp;issue=4&amp;publication_year=2010&amp;pages=332-7&amp;pmid=20228799&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">McGovern DP, et al.  Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>(17):3468–76.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2916706/">PMC free article</a>]</span> [<a href="/pubmed/20570966" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet&amp;title=Fucosyltransferase+2+(FUT2)+non-secretor+status+is+associated+with+Crohn's+disease&amp;author=DP+McGovern&amp;volume=19&amp;issue=17&amp;publication_year=2010&amp;pages=3468-76&amp;pmid=20570966&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Hadi A, Lebwohl M. Clinical features of pyoderma gangrenosum and current diagnostic trends. <span><span class="ref-journal">J Am Acad Dermatol. </span>2011;<span class="ref-vol">64</span>(5):950–4.</span> [<a href="/pubmed/21292348" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Clinical+features+of+pyoderma+gangrenosum+and+current+diagnostic+trends&amp;author=A+Hadi&amp;author=M+Lebwohl&amp;volume=64&amp;issue=5&amp;publication_year=2011&amp;pages=950-4&amp;pmid=21292348&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Diseases, N.I.o.D.a.D.a.K. Inflammatory Bowel Disease Genetics Consortium. <span>2012</span> [cited 2012 2012]; Available from:  <a href="http://medicine.yale.edu/intmed/ibdgc" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://medicine.yale.edu/intmed/ibdgc</a>.</span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Dassopoulos T, et al.  Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC) <span><span class="ref-journal">Inflamm Bowel Dis. </span>2007;<span class="ref-vol">13</span>(8):975–83.</span> [<a href="/pubmed/17427244" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm+Bowel+Dis&amp;title=Assessment+of+reliability+and+validity+of+IBD+phenotyping+within+the+National+Institutes+of+Diabetes+and+Digestive+and+Kidney+Diseases+(NIDDK)+IBD+Genetics+Consortium+(IBDGC)&amp;author=T+Dassopoulos&amp;volume=13&amp;issue=8&amp;publication_year=2007&amp;pages=975-83&amp;pmid=17427244&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Silverberg MS, et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. <span><span class="ref-journal">Can J Gastroenterol. </span>2005;<span class="ref-vol">19</span>(Suppl A):5–36.</span> [<a href="/pubmed/16151544" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Can+J+Gastroenterol&amp;title=Toward+an+integrated+clinical,+molecular+and+serological+classification+of+inflammatory+bowel+disease:+Report+of+a+Working+Party+of+the+2005+Montreal+World+Congress+of+Gastroenterology&amp;author=MS+Silverberg&amp;volume=19&amp;issue=Suppl+A&amp;publication_year=2005&amp;pages=5-36&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Dubinsky MC, et al.  Increased immune reactivity predicts aggressive complicating Crohn's disease in children. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2008;<span class="ref-vol">6</span>(10):1105–11.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3745777/">PMC free article</a>]</span> [<a href="/pubmed/18619921" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Gastroenterol+Hepatol&amp;title=Increased+immune+reactivity+predicts+aggressive+complicating+Crohn's+disease+in+children&amp;author=MC+Dubinsky&amp;volume=6&amp;issue=10&amp;publication_year=2008&amp;pages=1105-11&amp;pmid=18619921&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Duerr RH, et al.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. <span><span class="ref-journal">Science. </span>2006;<span class="ref-vol">314</span>(5804):1461–3.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4410764/">PMC free article</a>]</span> [<a href="/pubmed/17068223" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=A+genome-wide+association+study+identifies+IL23R+as+an+inflammatory+bowel+disease+gene&amp;author=RH+Duerr&amp;volume=314&amp;issue=5804&amp;publication_year=2006&amp;pages=1461-3&amp;pmid=17068223&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Silverberg MS, et al.  Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>(2):216–20.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2652837/">PMC free article</a>]</span> [<a href="/pubmed/19122664" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Ulcerative+colitis-risk+loci+on+chromosomes+1p36+and+12q15+found+by+genome-wide+association+study&amp;author=MS+Silverberg&amp;volume=41&amp;issue=2&amp;publication_year=2009&amp;pages=216-20&amp;pmid=19122664&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Anderson CA, et al.  Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>(3):246–52.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3084597/">PMC free article</a>]</span> [<a href="/pubmed/21297633" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Meta-analysis+identifies+29+additional+ulcerative+colitis+risk+loci,+increasing+the+number+of+confirmed+associations+to+47&amp;author=CA+Anderson&amp;volume=43&amp;issue=3&amp;publication_year=2011&amp;pages=246-52&amp;pmid=21297633&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Franke A, et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>(12):1118–25.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3299551/">PMC free article</a>]</span> [<a href="/pubmed/21102463" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+meta-analysis+increases+to+71+the+number+of+confirmed+Crohn's+disease+susceptibility+loci&amp;author=A+Franke&amp;volume=42&amp;issue=12&amp;publication_year=2010&amp;pages=1118-25&amp;pmid=21102463&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Kattan MW, Scardino PT. Prediction of progression: nomograms of clinical utility. <span><span class="ref-journal">Clin Prostate Cancer. </span>2002;<span class="ref-vol">1</span>(2):90–6.</span> [<a href="/pubmed/15046699" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Prostate+Cancer&amp;title=Prediction+of+progression:+nomograms+of+clinical+utility&amp;author=MW+Kattan&amp;author=PT+Scardino&amp;volume=1&amp;issue=2&amp;publication_year=2002&amp;pages=90-6&amp;pmid=15046699&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Polcz M, Gu J, Florin T. Pyoderma gangrenosum in inflammatory bowel disease: the experience at Mater Health Services' Adult Hospital 1998-2009. <span><span class="ref-journal">J Crohns Colitis. </span>2011;<span class="ref-vol">5</span>(2):148–51.</span> [<a href="/pubmed/21453884" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Crohns+Colitis&amp;title=Pyoderma+gangrenosum+in+inflammatory+bowel+disease:+the+experience+at+Mater+Health+Services'+Adult+Hospital+1998-2009&amp;author=M+Polcz&amp;author=J+Gu&amp;author=T+Florin&amp;volume=5&amp;issue=2&amp;publication_year=2011&amp;pages=148-51&amp;pmid=21453884&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Veloso FT. Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome? <span><span class="ref-journal">World J Gastroenterol. </span>2011;<span class="ref-vol">17</span>(22):2702–7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3122258/">PMC free article</a>]</span> [<a href="/pubmed/21734777" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+J+Gastroenterol&amp;title=Extraintestinal+manifestations+of+inflammatory+bowel+disease:+do+they+influence+treatment+and+outcome?&amp;author=FT+Veloso&amp;volume=17&amp;issue=22&amp;publication_year=2011&amp;pages=2702-7&amp;pmid=21734777&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Powell FC, et al.  Pyoderma gangrenosum: a review of 86 patients. <span><span class="ref-journal">Q J Med. </span>1985;<span class="ref-vol">55</span>(217):173–86.</span> [<a href="/pubmed/3889978" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Q+J+Med&amp;title=Pyoderma+gangrenosum:+a+review+of+86+patients&amp;author=FC+Powell&amp;volume=55&amp;issue=217&amp;publication_year=1985&amp;pages=173-86&amp;pmid=3889978&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Monsen U, et al.  Extracolonic diagnoses in ulcerative colitis: an epidemiological study. <span><span class="ref-journal">Am J Gastroenterol. </span>1990;<span class="ref-vol">85</span>(6):711–6.</span> [<a href="/pubmed/2353691" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Gastroenterol&amp;title=Extracolonic+diagnoses+in+ulcerative+colitis:+an+epidemiological+study&amp;author=U+Monsen&amp;volume=85&amp;issue=6&amp;publication_year=1990&amp;pages=711-6&amp;pmid=2353691&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Bhagat S, Das KM. A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody. <span><span class="ref-journal">Gastroenterology. </span>1994;<span class="ref-vol">107</span>(1):103–8.</span> [<a href="/pubmed/8020652" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=A+shared+and+unique+peptide+in+the+human+colon,+eye,+and+joint+detected+by+a+monoclonal+antibody&amp;author=S+Bhagat&amp;author=KM+Das&amp;volume=107&amp;issue=1&amp;publication_year=1994&amp;pages=103-8&amp;pmid=8020652&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">Ruemmele FM, et al.  Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. <span><span class="ref-journal">Gastroenterology. </span>1998;<span class="ref-vol">115</span>(4):822–9.</span> [<a href="/pubmed/9753483" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Diagnostic+accuracy+of+serological+assays+in+pediatric+inflammatory+bowel+disease&amp;author=FM+Ruemmele&amp;volume=115&amp;issue=4&amp;publication_year=1998&amp;pages=822-9&amp;pmid=9753483&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="element-citation">Quinton JF, et al.  Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. <span><span class="ref-journal">Gut. </span>1998;<span class="ref-vol">42</span>(6):788–91.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1727156/">PMC free article</a>]</span> [<a href="/pubmed/9691915" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Anti-Saccharomyces+cerevisiae+mannan+antibodies+combined+with+antineutrophil+cytoplasmic+autoantibodies+in+inflammatory+bowel+disease:+prevalence+and+diagnostic+role&amp;author=JF+Quinton&amp;volume=42&amp;issue=6&amp;publication_year=1998&amp;pages=788-91&amp;pmid=9691915&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="element-citation">Vasiliauskas EA, et al.  Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. <span><span class="ref-journal">Gastroenterology. </span>1996;<span class="ref-vol">110</span>(6):1810–9.</span> [<a href="/pubmed/8964407" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Perinuclear+antineutrophil+cytoplasmic+antibodies+in+patients+with+Crohn's+disease+define+a+clinical+subgroup&amp;author=EA+Vasiliauskas&amp;volume=110&amp;issue=6&amp;publication_year=1996&amp;pages=1810-9&amp;pmid=8964407&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="element-citation">Hov JR, et al.  TGR5 sequence variation in primary sclerosing cholangitis. <span><span class="ref-journal">Dig Dis. </span>2011;<span class="ref-vol">29</span>(1):78–84.</span> [<a href="/pubmed/21691110" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dig+Dis&amp;title=TGR5+sequence+variation+in+primary+sclerosing+cholangitis&amp;author=JR+Hov&amp;volume=29&amp;issue=1&amp;publication_year=2011&amp;pages=78-84&amp;pmid=21691110&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="element-citation">Information, T.N.C.f.B. GPBAR1 G protein-coupled bile acid receptor 1 [Homo sapiens] <span>2012</span> [cited 2012 2012]; Available from:  <a href="http://www.ncbi.nlm.nih.gov/gene/151306" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/gene/151306</a>.</span></div><div class="ref-cit-blk half_rhythm" id="R46">46. <span class="element-citation">Information, T.N.C.f.B. TIMP3 TIMP metallopeptidase inhibitor 3 [Homo sapiens] <span>2012</span> [cited 2012 2012]; Available from:  <a href="http://www.ncbi.nlm.nih.gov/gene/7078" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/gene/7078</a>.</span></div><div class="ref-cit-blk half_rhythm" id="R47">47. <span class="element-citation">Alberts B, et al.  Cell junctions, cell adhesion, and the extracellular matrix. <span><span class="ref-journal">Molecular Biology of the Cell. </span>2002:1065–125.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+Biology+of+the+Cell&amp;title=Cell+junctions,+cell+adhesion,+and+the+extracellular+matrix&amp;author=B+Alberts&amp;publication_year=2002&amp;pages=1065-125&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R48">48. <span class="element-citation">Wu Y, et al.  A chemokine receptor CXCR2 macromolecular complex regulates neutrophil functions in inflammatory diseases. <span><span class="ref-journal">J Biol Chem. </span>2012;<span class="ref-vol">287</span>(8):5744–55.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3285346/">PMC free article</a>]</span> [<a href="/pubmed/22203670" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=A+chemokine+receptor+CXCR2+macromolecular+complex+regulates+neutrophil+functions+in+inflammatory+diseases&amp;author=Y+Wu&amp;volume=287&amp;issue=8&amp;publication_year=2012&amp;pages=5744-55&amp;pmid=22203670&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R49">49. <span class="element-citation">Lichtenstein GR, et al.  Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior. <span><span class="ref-journal">Inflamm Bowel Dis. </span>2011;<span class="ref-vol">17</span>(12):2488–96.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4203682/">PMC free article</a>]</span> [<a href="/pubmed/21391291" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm+Bowel+Dis&amp;title=Combination+of+genetic+and+quantitative+serological+immune+markers+are+associated+with+complicated+Crohn's+disease+behavior&amp;author=GR+Lichtenstein&amp;volume=17&amp;issue=12&amp;publication_year=2011&amp;pages=2488-96&amp;pmid=21391291&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R50">50. <span class="element-citation">Dubinsky MC, et al.  Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease. <span><span class="ref-journal">Inflamm Bowel Dis. </span>2010;<span class="ref-vol">16</span>(8):1357–66.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2889173/">PMC free article</a>]</span> [<a href="/pubmed/20014019" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm+Bowel+Dis&amp;title=Genome+wide+association+(GWA)+predictors+of+anti-TNFalpha+therapeutic+responsiveness+in+pediatric+inflammatory+bowel+disease&amp;author=MC+Dubinsky&amp;volume=16&amp;issue=8&amp;publication_year=2010&amp;pages=1357-66&amp;pmid=20014019&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R51">51. <span class="element-citation">Bevilacqua JL, et al.  Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. <span><span class="ref-journal">J Clin Oncol. </span>2007;<span class="ref-vol">25</span>(24):3670–9.</span> [<a href="/pubmed/17664461" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Doctor,+what+are+my+chances+of+having+a+positive+sentinel+node?+A+validated+nomogram+for+risk+estimation&amp;author=JL+Bevilacqua&amp;volume=25&amp;issue=24&amp;publication_year=2007&amp;pages=3670-9&amp;pmid=17664461&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R52">52. <span class="element-citation">Danese S, et al.  Extraintestinal manifestations in inflammatory bowel disease. <span><span class="ref-journal">World J Gastroenterol. </span>2005;<span class="ref-vol">11</span>(46):7227–36.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4725142/">PMC free article</a>]</span> [<a href="/pubmed/16437620" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+J+Gastroenterol&amp;title=Extraintestinal+manifestations+in+inflammatory+bowel+disease&amp;author=S+Danese&amp;volume=11&amp;issue=46&amp;publication_year=2005&amp;pages=7227-36&amp;pmid=16437620&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R53">53. <span class="element-citation">Goudet P, et al.  Characteristics and evolution of extraintestinal manifestations associated with ulcerative colitis after proctocolectomy. <span><span class="ref-journal">Dig Surg. </span>2001;<span class="ref-vol">18</span>(1):51–5.</span> [<a href="/pubmed/11244260" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dig+Surg&amp;title=Characteristics+and+evolution+of+extraintestinal+manifestations+associated+with+ulcerative+colitis+after+proctocolectomy&amp;author=P+Goudet&amp;volume=18&amp;issue=1&amp;publication_year=2001&amp;pages=51-5&amp;pmid=11244260&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R54">54. <span class="element-citation">Fleisher M, et al.  Infliximab in the treatment of steroid refractory erythema nodosum of IBD. <span><span class="ref-journal">Gastroenterology. </span>2002;<span class="ref-vol">122</span>(Suppl 1):A618.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Infliximab+in+the+treatment+of+steroid+refractory+erythema+nodosum+of+IBD&amp;author=M+Fleisher&amp;volume=122&amp;issue=Suppl+1&amp;publication_year=2002&amp;pages=A618&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R55">55. <span class="element-citation">Mendoza JL, et al.  [Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis] <span><span class="ref-journal">Med Clin (Barc) </span>2005;<span class="ref-vol">125</span>(8):297–300.</span> [<a href="/pubmed/16159555" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Clin+(Barc)&amp;title=[Extraintestinal+manifestations+in+inflammatory+bowel+disease:+differences+between+Crohn's+disease+and+ulcerative+colitis]&amp;author=JL+Mendoza&amp;volume=125&amp;issue=8&amp;publication_year=2005&amp;pages=297-300&amp;pmid=16159555&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R56">56. <span class="element-citation">Georgiou S, et al.  Cutaneous Manifestations of Inflammatory Bowel Disease. <span><span class="ref-journal">Hospital Chronicles. </span>2006;<span class="ref-vol">1</span>(3):158–168.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hospital+Chronicles&amp;title=Cutaneous+Manifestations+of+Inflammatory+Bowel+Disease&amp;author=S+Georgiou&amp;volume=1&amp;issue=3&amp;publication_year=2006&amp;pages=158-168&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R57">57. <span class="element-citation">Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. <span><span class="ref-journal">J Clin Gastroenterol. </span>1996;<span class="ref-vol">23</span>(1):29–34.</span> [<a href="/pubmed/8835896" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Gastroenterol&amp;title=Immune-related+systemic+manifestations+of+inflammatory+bowel+disease.+A+prospective+study+of+792+patients&amp;author=FT+Veloso&amp;author=J+Carvalho&amp;author=F+Magro&amp;volume=23&amp;issue=1&amp;publication_year=1996&amp;pages=29-34&amp;pmid=8835896&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R58">58. <span class="element-citation">Papp M, et al.  Utility of serological markers in inflammatory bowel diseases: gadget or magic? <span><span class="ref-journal">World J Gastroenterol. </span>2007;<span class="ref-vol">13</span>(14):2028–36.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4319120/">PMC free article</a>]</span> [<a href="/pubmed/17465443" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+J+Gastroenterol&amp;title=Utility+of+serological+markers+in+inflammatory+bowel+diseases:+gadget+or+magic?&amp;author=M+Papp&amp;volume=13&amp;issue=14&amp;publication_year=2007&amp;pages=2028-36&amp;pmid=17465443&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R59">59. <span class="element-citation">Information, T.N.C.f.B. SOCS5 suppressor of cytokine signaling 5 [Homo sapiens] <span>2012</span> [cited 2012 2012]; Available from:  <a href="http://www.ncbi.nlm.nih.gov/gene/9655#reference-sequences" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/gene/9655#reference-sequences</a>.</span></div><div class="ref-cit-blk half_rhythm" id="R60">60. <span class="element-citation">Information, T.N.C.f.B. CD207 molecule, langerin [Homo sapiens] <span>2012</span> [cited 2012 2012]; Available from:  <a href="http://www.ncbi.nlm.nih.gov/gene/50489" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/gene/50489</a>.</span></div><div class="ref-cit-blk half_rhythm" id="R61">61. <span class="element-citation">Information, T.N.C.f.B. ITGB3 integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) [Homo sapiens] <span>2012</span> [cited 2012 2012]; Available from:  <a href="http://www.ncbi.nlm.nih.gov/gene/3690" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4046633&amp;issue-id=238634&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/gene/3690</a>.</span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140122008025328title">Abstract</a></li><li><a href="#S5title">Introduction</a></li><li><a href="#S6title">Methods</a></li><li><a href="#S15title">Results</a></li><li><a href="#S26title">Discussion</a></li><li><a href="#S27title">Supplementary Material</a></li><li><a href="#S28title">Acknowledgments</a></li><li><a href="#idm140122005957648title">Footnotes</a></li><li><a href="#idm140122005954928title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC4046633/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC4046633/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC4046633/pdf/nihms554731.pdf">PDF (165K)</a></li> | <li><a href="#" data-citationid="PMC4046633" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4046633%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4046633%2F&amp;text=Clinical%2C%20serologic%2C%20and%20genetic%20factors%20associated%20with%20pyoderma%20gangrenosum%20and%20erythema%20nodosum%20in%20inflammatory%20bowel%20disease%20patients" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4046633%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="24487271" data-aiid="4046633" data-aid="4046633" data-iid="238634" data-domainid="319" data-domain="nihpa" data-accid="PMC4046633" data-md5="ad504a634b84815a59df9007370850d6"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T11:48:11-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal104&amp;ncbi_phid=CE8B32B3DD56A37100000000031501DA&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4046633%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC4046633/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>